drugset / Trial / NCT02635282

IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D

NCT02635282 ↗

Phase 4 Completed 19 enrolled University of Tennessee
RandomizedParallel-groupOpen-labelTreatment

Summary

The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.

Timeline

Start
2016-08
Primary completion
2017-03-23
Completion
2017-03-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified — Other
Subject Ketamine Small molecule — Other
Comparator Midazolam Small molecule — Other

Indications